2020
DOI: 10.1016/j.ijpharm.2020.119605
|View full text |Cite
|
Sign up to set email alerts
|

Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
24
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 69 publications
2
24
0
Order By: Relevance
“…87 Yameen's group developed novel enzyme-responsive DEX based oligoester crosslinked NPs for the controlled release of an anticancer drug, 5-fluorouracil (5-FU). 217 The results obtained from their study showed that 5-FU was effectively encapsulated in the DEXNPs (Fig. 10), and the synthesised DEXNPs maintained their stability at pH conditions representative of specific in vivo environments (e.g.…”
Section: Polysaccharide Nanoparticles In Nanomedicinementioning
confidence: 96%
“…87 Yameen's group developed novel enzyme-responsive DEX based oligoester crosslinked NPs for the controlled release of an anticancer drug, 5-fluorouracil (5-FU). 217 The results obtained from their study showed that 5-FU was effectively encapsulated in the DEXNPs (Fig. 10), and the synthesised DEXNPs maintained their stability at pH conditions representative of specific in vivo environments (e.g.…”
Section: Polysaccharide Nanoparticles In Nanomedicinementioning
confidence: 96%
“…which can be simply modified by an organic reaction. Due to these characteristics, polysaccharides are widely used as a platform in applications such as green electronics, nanoparticles, and hydrogels through chemical modification [3][4][5][6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…Controlled drug release of 5-FU has been demonstrated by loading it onto colonic enzyme-responsive dextran-based oligoester NPs. The enzyme dextranase triggered the release of the encapsulated drug, and the actions of this enzyme were likely the cause of the increased bioavailability and elevated toxicity of the nano formula for the treatment of colorectal cancer ( Abid, 2020 ).…”
Section: Introductionmentioning
confidence: 99%